• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Drug-Drug interactions of docetaxel in patients with breast cancer based on insurance claims data
In conclusion, we suggest that coadministration of docetaxel and a predefined interacting drug are not associated with G-CSF prescription.PMID:37327237 | PMC:PMC10275435 | DOI:10.1371/journal.pone.0287382
Source: Cancer Control - June 16, 2023 Category: Cancer & Oncology Authors: Kwang-Hee Shin Young-Mi Ah Sang Hun Cha Hye Duck Choi Source Type: research

Cost-effectiveness of trastuzumab biosimilar combination therapy and drug wastage as first-line treatment for HER2-positive metastatic breast cancer
CONCLUSION: The trastuzumab biosimilar combination regimen is cost-effective and offers significant drug cost savings in Taiwan.PMID:35870421 | PMC:PMC9305615 | DOI:10.1016/j.breast.2022.07.007
Source: Breast - July 23, 2022 Category: Cancer & Oncology Authors: John Hang Leung Yun-Sheng Tai Shyh-Yau Wang Hei-Tung Yip Fion Ho Tsung-Chin Agnes Lf Chan Source Type: research

Treatment Intensification Patterns and Utilization in Patients with Metastatic Castration-Sensitive Prostate Cancer
CONCLUSION: Both medical oncology and urology providers need to improve their treatment intensification efforts for men with mCSPC to increase their patients' overall survival.PMID:35864053 | DOI:10.1016/j.clgc.2022.06.017
Source: Clinical Prostate Cancer - July 21, 2022 Category: Cancer & Oncology Authors: Elisabeth I Heath Gregory E Dyson Frank C Cackowski Jason Hafron Isaac Powell Source Type: research